Psyence Biomedical Ltd [NASDAQ: PBM] traded at a low on 2025-12-09, posting a -5.92 loss after which it closed the day’ session at $1.59.
The results of the trading session contributed to over 15370363 shares changing hands. Over the past one week, the price volatility of Psyence Biomedical Ltd stands at 13.88% while the volatility over the past one month is 13.18%.
The market cap for PBM stock reached $2.97 million, with 1.87 million shares outstanding. Compared to the average trading volume of 933.98K shares, PBM reached a trading volume of 15370363 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Psyence Biomedical Ltd [PBM]?
The Price to Book ratio for the last quarter was 0.25, with the Price to Cash per share for the same quarter was set at 3.85.
How has PBM stock performed recently?
Psyence Biomedical Ltd [PBM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.63. With this latest performance, PBM shares dropped by -31.17% in over the last four-week period, additionally sinking by -69.54% over the last 6 months – not to mention a drop of -90.55% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PBM stock in for the last two-week period is set at 33.87, with the RSI for the last a single of trading hit 0.2343, and the three-weeks RSI is set at 0.2757 for Psyence Biomedical Ltd [PBM]. The present Moving Average for the last 50 days of trading for this stock 2.7610, while it was recorded at 1.7260 for the last single week of trading, and 4.3002 for the last 200 days.
Psyence Biomedical Ltd (PBM) Capital Structure & Debt Analysis
Psyence Biomedical Ltd (PBM) Efficiency & Liquidity Metrics
Based on Psyence Biomedical Ltd’s (PBM) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Psyence Biomedical Ltd (PBM) Efficiency & Liquidity Metrics
Insider trade positions for Psyence Biomedical Ltd [PBM]
There are presently around $10.06%, or 10.08%% of PBM stock, in the hands of institutional investors. The top three institutional holders of PBM stocks are: ADVISORSHARES INVESTMENTS LLC with ownership of 0.46 million shares, which is approximately 23.9034%. CANTOR FITZGERALD, L. P., holding 0.34 million shares of the stock with an approximate value of $$0.1 million in PBM stocks shares; and CANTOR FITZGERALD, L. P., currently with $$6866.0 in PBM stock with ownership which is approximately 1.1814%.
